Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan 29:10:885-91.
doi: 10.2147/IJN.S78675. eCollection 2015.

Sustained release of vancomycin from novel biodegradable nanofiber-loaded vascular prosthetic grafts: in vitro and in vivo study

Kuo-Sheng Liu  1 , Cheng-Hung Lee  2 , Yi-Chuan Wang  3 , Shih-Jung Liu  3
Affiliations

Sustained release of vancomycin from novel biodegradable nanofiber-loaded vascular prosthetic grafts: in vitro and in vivo study

Kuo-Sheng Liu et al. Int J Nanomedicine. .

Abstract

This study describes novel biodegradable, drug-eluting nanofiber-loaded vascular prosthetic grafts that provide local and sustained delivery of vancomycin to surrounding tissues. Biodegradable nanofibers were prepared by first dissolving poly(D,L)-lactide-co-glycolide and vancomycin in 1,1,1,3,3,3-hexafluoro-2-propanol. The solution was then electrospun into nanofibers onto the surface of vascular prostheses. The in vitro release rates of the pharmaceutical from the nanofiber-loaded prostheses was characterized using an elution method and a high-performance liquid chromatography assay. Experimental results indicated that the drug-eluting prosthetic grafts released high concentrations of vancomycin in vitro (well above the minimum inhibitory concentration) for more than 30 days. In addition, the in vivo release behavior of the drug-eluting grafts implanted in the subcutaneous pocket of rabbits was also documented. The drug-eluting grafts developed in this work have potential applications in assisting the treatment of vascular prosthesis infection and resisting reinfection when an infected graft is to be exchanged.

Keywords: drug-eluting prosthetic graft; release characteristics; vascular prosthesis infection.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The electrospinning setup shown schematically.
Figure 2
Figure 2
Photograph of the vascular prosthetic grafts (top, loaded with nanofibers; bottom, bare graft).
Figure 3
Figure 3
SEM photograph of electrospun drug-eluting nanofibers. Abbreviation: SEM, scanning electron microscope.
Figure 4
Figure 4
In vitro release of vancomycin from the drug-eluting grafts (n=3). Notes: (A) Daily release, and (B) accumulated release. Abbreviation: MIC90, 90% minimum inhibitory concentration.
Figure 5
Figure 5
The implantation of drug-eluting grafts into the subcutaneous pockets of rabbits. Notes: (A) The drug-eluting graft was cut into 2 cm in length. (B) The implantation of drug-eluting grafts into the subcutaneous pockets of rabbits.
Figure 6
Figure 6
In vivo release behavior of the drug-eluting grafts.
See this image and copyright information in PMC

References

    1. Ryan SV, Calligaro KD, Scharff J, Dougherty MJ. Management of infected prosthetic dialysis arteriovenous grafts. J Vasc Surg. 2004;39(1):73–78. - PubMed
    1. Liu C, Bayer A, Cosgrove SE, et al. Infectious Diseases Society of America Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52(3):e18–e55. - PubMed
    1. Peng CW, Tan SG. Polyurethane grafts: a viable alternative for dialysis arteriovenous access? Asian Cardiovasc Thorac Ann. 2003;11(4):314–318. - PubMed
    1. Englesbe MJ, Al-Holou WN, Moyer AT, et al. Single center review of femoral arteriovenous grafts for hemodialysis. World J Surg. 2006;30(2):171–175. - PubMed
    1. Schutte WP, Helmer SD, Salazar L, Smith JL. Surgical treatment of infected prosthetic dialysis arteriovenous grafts: total versus partial graft excision. Am J Surg. 2007;193(3):385–388. discussion 388. - PubMed

Publication types